One would think yet stock has moved down after the news. biotech bear market continues. thanks Billary
Will get royalties on REGN product or maybe even an injunction. Doctors will now be afraid to prescribe REGN product and will default to AMGN. Put a reasonable 16x multiple and AMGN is a $175 stock - huge upside!
Sentiment: Strong Buy
Heck, now I'm reading that the ruling was in favor of AMGN defense ... guess we'll just have to see which way the stock goes. . . sorry about the first post, news is confusing.
Sanofi and Regeneron have already conceded that they are infringing Amgen patents. They are arguing that the patents are invalid. The jury had to decidede whether patents are valid. I bet Amen won.
AMGN is the one you buy. Great pipeline, Tons of cash, Good buyback and a nice yield. The dividend at 2.7% will provide support compared to treasuries. I think the worst case is it restests the old high at $124. I have some bids at that price just in case. I doubt I get that lucky, but you never know.